109119 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation; Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos; Techniques for producing new mammalian cloned embryos Primate embryos
PARTHENOGENIC ACTIVATION OF HUMAN OOCYTES FOR THE PRODUCTION OF HUMAN EMBRYONIC STEM CELLS
#2METHODS FOR MAKING AND USING MODIFIED OOCYTES
#3Method for preparing non-human primate somatic cell cloned animal
#4METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC
#5Methods for making and using modified oocytes
#6Methods of enhancing chromosomal homologous recombination
#7Methods of enhancing female fertility
#8METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC
#9Somatic cell nuclear transfer methods
#10Methods for making and using modified oocytes
#11Mitochondrial Collection and Concentration, and Uses Thereof
#12Parthenogenic activation of human oocytes for the production of neuronal cells
#13METHODS FOR IN VITRO MATURATION OF OVARIAN FOLLICLES
#14Somatic cell nuclear transfer methods
#15Human pluripotent embryonic stem cells produced by nuclear transfer using a somatic cell nucleus treated with HVJ-E extract and an oocyte from a donor cycle that produced 15 or fewer oocytes
#16Methods for making and using modified oocytes
#17Neuro-progenitor produced from an SCNT-derived ES cell
#18Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
#19Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension
#20METHOD AND SYSTEM FOR SOMATIC CELL NUCLEAR TRANSFER
#21Human embryonic stem cell line prepared by nuclear transfer of a human somatic cell into an enucleated human oocyte
#22Methods for mitochondrial DNA replacement in oocytes
#23Embryonic stem cell line and method for preparing the same
#24Methods for in vitro maturation of ovarian follicles
#25Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
#26Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#27METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS AND OPTIMIZING PREIMPLANTATION EMBRYONIC DEVELOPMENTAL RATES ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS
#28Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#29METHODS FOR MAKING AND USING REPROGRAMMED HUMAN SOMATIC CELL NUCLEI AND AUTOLOGOUS AND ISOGENIC HUMAN STEM CELLS
#30METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS AND OPTIMIZING PREIMPLANTATION EMBRYONIC DEVELOPMENTAL RATES ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS
#31METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS
#32Embryonic Stem Cell Line and Method for Preparing the Same
#33Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells
#34Methods of developing a stem cell line
#35Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals
#36Embryonic or stem-like cell lines produced by cross species nuclear transplantation
#37Method of enucleation and oocyte activation in somatic cell nuclear transfer in primates